Consistently, as shown in Table 4, strong expression of CD4 was detected in 90% (36/40) of stage I lung cancer tissues, which was significantly higher than the percentage of weak CD4 expression (10%, 4/40, P < 0.05). This evidence concerns the gene CD4 and lung carcinoma.